Lin Qiang - Net Worth and Insider Trading

Lin Qiang Net Worth

The estimated net worth of Lin Qiang is at least $62 Million dollars as of 2025-07-19. Lin Qiang is the Directors, Directors, and Executives of Sichuan Goldstone Asia Pharmaceutical Inc and owns about 5,764,800 shares of Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) stock worth over $62 Million. Details can be seen in Lin Qiang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lin Qiang has not made any transactions after 2025-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Lin Qiang

To

Lin Qiang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lin Qiang owns 1 companies in total, including Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) .

Click here to see the complete history of Lin Qiang’s form 4 insider trades.

Insider Ownership Summary of Lin Qiang

Ticker Company Transaction Date Type of Owner
SZSE:300434 Sichuan Goldstone Asia Pharmaceutical Inc 2025-07-16 Directors & Directors & and Executives

Lin Qiang Latest Holdings Summary

Lin Qiang currently owns a total of 1 stock. Lin Qiang owns 5,764,800 shares of Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) as of July 16, 2025, with a value of $62 Million.

Latest Holdings of Lin Qiang

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300434 Sichuan Goldstone Asia Pharmaceutical Inc 2025-07-16 5,764,800 10.70 61,683,360

Holding Weightings of Lin Qiang


Lin Qiang Form 4 Trading Tracker

According to the SEC Form 4 filings, Lin Qiang has made a total of 3 transactions in Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Sichuan Goldstone Asia Pharmaceutical Inc is the sale of 400,000 shares on July 16, 2025, which brought Lin Qiang around $4 Million.

Insider Trading History of Lin Qiang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lin Qiang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lin Qiang Ownership Network

Ownership Network List of Lin Qiang

No Data

Ownership Network Relation of Lin Qiang

Insider Network Chart


Lin Qiang Owned Company Details

What does Sichuan Goldstone Asia Pharmaceutical Inc do?

Who are the key executives at Sichuan Goldstone Asia Pharmaceutical Inc?

Lin Qiang is the Directors & Directors & and Executives of Sichuan Goldstone Asia Pharmaceutical Inc. Other key executives at Sichuan Goldstone Asia Pharmaceutical Inc include Directors & executives Wei Bao Kang , Executives Chen Shao Jiang , and Supervisors Lai Xing Feng .

Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) Insider Trades Summary

Over the past 18 months, Lin Qiang made 2 insider transaction in Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) with a net sale of 500,000.

In summary, during the past 3 months, insiders sold 500,000 shares of Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) in total and bought 0 shares, with a net sale of 500,000 shares. During the past 18 months, 500,000 shares of Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) were sold and 0 shares were bought by its insiders, resulting in a net sale of 500,000 shares.

Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sichuan Goldstone Asia Pharmaceutical Inc Insider Transactions

No Available Data

Lin Qiang Mailing Address

Above is the net worth, insider trading, and ownership report for Lin Qiang. Currently GuruFocus does not have mailing address information for Lin Qiang.